Elevated Fra-1 expression causes severe lipodystrophy
Standard
Elevated Fra-1 expression causes severe lipodystrophy. / Luther, Julia; Driessler, Frank; Megges, Matthias; Hess, Andreas; Herbort, Bettina; Mandic, Vice; Zaiss, Mario M; Reichardt, Anne; Zech, Christine; Tuckermann, Jan P; Calkhoven, Cornelis F; Wagner, Erwin F; Schett, Georg; David, Jean-Pierre.
In: J CELL SCI, Vol. 124, No. Pt 9, 01.05.2011, p. 1465-76.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Elevated Fra-1 expression causes severe lipodystrophy
AU - Luther, Julia
AU - Driessler, Frank
AU - Megges, Matthias
AU - Hess, Andreas
AU - Herbort, Bettina
AU - Mandic, Vice
AU - Zaiss, Mario M
AU - Reichardt, Anne
AU - Zech, Christine
AU - Tuckermann, Jan P
AU - Calkhoven, Cornelis F
AU - Wagner, Erwin F
AU - Schett, Georg
AU - David, Jean-Pierre
PY - 2011/5/1
Y1 - 2011/5/1
N2 - A shift from osteoblastogenesis to adipogenesis is one of the underlying mechanisms of decreased bone mass and increased fat during aging. We now uncover a new role for the transcription factor Fra-1 in suppressing adipogenesis. Indeed, Fra1 (Fosl1) transgenic (Fra1tg) mice, which developed progressive osteosclerosis as a result of accelerated osteoblast differentiation, also developed a severe general lipodystrophy. The residual fat of these mice appeared immature and expressed lower levels of adipogenic markers, including the fatty acid transporter Cd36 and the CCAAT/enhancer binding protein Cebpa. Consequently accumulation of triglycerides and free fatty acids were detected in the serum of fasting Fra1tg mice. Fra-1 acts cell autonomously because the adipogenic differentiation of Fra1 transgenic primary osteoblasts was drastically reduced, and overexpression of Fra-1 in an adipogenic cell line blocked their differentiation into adipocytes. Strikingly, Cebpa was downregulated in the Fra-1-overexpressing cells and Fra-1 could bind to the Cebpa promoter and directly suppress its activity. Thus, our data add to the known common systemic control of fat and bone mass, a new cell-autonomous level of control of cell fate decision by which the osteogenic transcription factor Fra-1 opposes adipocyte differentiation by inhibiting C/EBPα.
AB - A shift from osteoblastogenesis to adipogenesis is one of the underlying mechanisms of decreased bone mass and increased fat during aging. We now uncover a new role for the transcription factor Fra-1 in suppressing adipogenesis. Indeed, Fra1 (Fosl1) transgenic (Fra1tg) mice, which developed progressive osteosclerosis as a result of accelerated osteoblast differentiation, also developed a severe general lipodystrophy. The residual fat of these mice appeared immature and expressed lower levels of adipogenic markers, including the fatty acid transporter Cd36 and the CCAAT/enhancer binding protein Cebpa. Consequently accumulation of triglycerides and free fatty acids were detected in the serum of fasting Fra1tg mice. Fra-1 acts cell autonomously because the adipogenic differentiation of Fra1 transgenic primary osteoblasts was drastically reduced, and overexpression of Fra-1 in an adipogenic cell line blocked their differentiation into adipocytes. Strikingly, Cebpa was downregulated in the Fra-1-overexpressing cells and Fra-1 could bind to the Cebpa promoter and directly suppress its activity. Thus, our data add to the known common systemic control of fat and bone mass, a new cell-autonomous level of control of cell fate decision by which the osteogenic transcription factor Fra-1 opposes adipocyte differentiation by inhibiting C/EBPα.
KW - Adipocytes
KW - Adipogenesis
KW - Animals
KW - Antigens, CD36
KW - Blotting, Western
KW - CCAAT-Enhancer-Binding Proteins
KW - Cells, Cultured
KW - Chromatin Immunoprecipitation
KW - Immunoprecipitation
KW - Lipodystrophy
KW - Magnetic Resonance Imaging
KW - Mice
KW - Mice, Inbred C57BL
KW - Mice, Transgenic
KW - Osteoblasts
KW - Osteogenesis
KW - Polymerase Chain Reaction
KW - Protein Binding
KW - Proto-Oncogene Proteins c-fos
U2 - 10.1242/jcs.079855
DO - 10.1242/jcs.079855
M3 - SCORING: Journal article
C2 - 21486951
VL - 124
SP - 1465
EP - 1476
JO - J CELL SCI
JF - J CELL SCI
SN - 0021-9533
IS - Pt 9
ER -